TY - JOUR
T1 - Evaluation of the iop-lowering effect of a multi-pressure dial at different negative pressure settings
AU - Swan, Russell J.
AU - Ferguson, Tanner J.
AU - Shah, Manjool
AU - Muir, Kelly W.
AU - Samuelson, Thomas W.
AU - Ahmed, Iqbal Ike K.
AU - Lindstrom, Richard L.
AU - Radcliffe, Nathan M.
AU - Berdahl, John P.
N1 - Publisher Copyright:
© 2020 The Authors.
PY - 2020/11
Y1 - 2020/11
N2 - Purpose: To evaluate the intraocular pressure (IOP)-lowering effect of a multi-pressure dial (MPD) at targeted negative pressure settings. Methods: Prospective, intrasubject controlled study of 65 healthy subjects randomized to receive no negative pressure for 60 minutes or negative pressure application at designated levels of 25%, 50%, and 75% of baseline IOP for 20 minutes each. The main outcome measure was mean IOP with application of negative pressure. Results: In the study eye group, from a baseline IOP of 15.8 ± 3.6 mm Hg, the mean IOP was 13.5 ± 3.4, 11.5 ± 3.1, and 10.2 ± 2.7 mm Hg with negative pressure settings of 25%, 50% and 75%, respectively. In the control eye group, from a baseline IOP of 15.5 ± 3.0 mm Hg, the mean IOP values at the same time points, without negative pressure, were 15.6 ± 3.0, 15.5 ± 2.5 and 15.3 ± 2.4 mm Hg. The difference between the mean IOPs of the two groups was significantly different at all negative pressure settings (P < 0.001) in comparison with baseline. There was one minor adverse event, a corneal abrasion, that was unrelated to device wear. Conclusions: Negative pressure application to the periocular space with a multi-pressure dial can produce titratable IOP reduction while the device is worn with active negative pressure. To our knowledge, this technology represents the first nonpharma-cologic, nonlaser, nonsurgical method for IOP reduction. Translational Relevance: This represents the first study demonstrating the IOP-lowering ability of the multi-pressure dial, a device that uses a novel IOP-lowering strat-egy by delivering negative pressure to the periocular region.
AB - Purpose: To evaluate the intraocular pressure (IOP)-lowering effect of a multi-pressure dial (MPD) at targeted negative pressure settings. Methods: Prospective, intrasubject controlled study of 65 healthy subjects randomized to receive no negative pressure for 60 minutes or negative pressure application at designated levels of 25%, 50%, and 75% of baseline IOP for 20 minutes each. The main outcome measure was mean IOP with application of negative pressure. Results: In the study eye group, from a baseline IOP of 15.8 ± 3.6 mm Hg, the mean IOP was 13.5 ± 3.4, 11.5 ± 3.1, and 10.2 ± 2.7 mm Hg with negative pressure settings of 25%, 50% and 75%, respectively. In the control eye group, from a baseline IOP of 15.5 ± 3.0 mm Hg, the mean IOP values at the same time points, without negative pressure, were 15.6 ± 3.0, 15.5 ± 2.5 and 15.3 ± 2.4 mm Hg. The difference between the mean IOPs of the two groups was significantly different at all negative pressure settings (P < 0.001) in comparison with baseline. There was one minor adverse event, a corneal abrasion, that was unrelated to device wear. Conclusions: Negative pressure application to the periocular space with a multi-pressure dial can produce titratable IOP reduction while the device is worn with active negative pressure. To our knowledge, this technology represents the first nonpharma-cologic, nonlaser, nonsurgical method for IOP reduction. Translational Relevance: This represents the first study demonstrating the IOP-lowering ability of the multi-pressure dial, a device that uses a novel IOP-lowering strat-egy by delivering negative pressure to the periocular region.
KW - CSF pressure
KW - MPD
KW - Multi-pressure dial
KW - Multi-pressure glaucoma management
KW - Normal tension glaucoma
KW - Open-angle glaucoma
KW - Severe open-angle glaucoma
UR - http://www.scopus.com/inward/record.url?scp=85097412850&partnerID=8YFLogxK
U2 - 10.1167/tvst.9.12.19
DO - 10.1167/tvst.9.12.19
M3 - Article
AN - SCOPUS:85097412850
SN - 2164-2591
VL - 9
SP - 1
EP - 9
JO - Translational Vision Science and Technology
JF - Translational Vision Science and Technology
IS - 12
M1 - 19
ER -